Zepbound vs Mounjaro: the same drug, two labels

Two things, and neither is the drug. The approved use: Mounjaro for diabetes, Zepbound for weight and for sleep apnea with obesity. And the packaging that follows each label. The dose ladder is identical, 2.5 mg up to 15 mg once weekly, in the same 2.5 mg steps; our posts on the Zepbound dosage levels and the Mounjaro dose chart walk through each.

Everything patients treat as a deep difference, how it feels, appetite, the side effects, is the same because it is the same medicine. The gap is regulatory and commercial, not pharmacological.

At the same dose, neither, because it is the same drug. Zepbound's obesity trials (SURMOUNT-1) reported average weight loss up to roughly 20 to 21% at the higher doses, and a person on Mounjaro at the same milligrams is taking the identical medicine and can expect a comparable effect.

So the honest framing is which dose you reach and can tolerate, not which brand. A person on Zepbound 15 mg and a person on Mounjaro 15 mg are on the same amount of the same drug.

This is where the two names matter. Insurers cover Mounjaro for type 2 diabetes and Zepbound for obesity, and routinely deny each for the other purpose. Diabetes usually points to Mounjaro as the covered path; treating weight without diabetes points to Zepbound, though obesity coverage is often patchy.

That is why so many people end up on Mounjaro off-label for weight: not because it is different or stronger, but because it can be the one their plan will pay for. Without coverage, both are expensive, since it is the same costly molecule.

Because it is one drug, the warnings are identical: severe persistent abdominal pain (pancreatitis territory), right-sided pain after fatty meals (gallbladder), vomiting past 24 hours (dehydration), low blood sugar when combined with insulin or a sulfonylurea, and the thyroid C-cell exclusion for a personal or family history of medullary thyroid cancer or MEN2. Tirzepatide can also reduce the effectiveness of oral birth control, so a backup method is advised around dose changes. Both are stopped before a planned pregnancy.

Our Zepbound and Mounjaro side-effect guides carry the full numbers, which apply equally whichever name is on your pen.

Start from your diagnosis and coverage, because those decide most cases. Diabetes usually means Mounjaro; weight management without diabetes means Zepbound where it is covered, with sleep apnea now a second on-label route for Zepbound. Your prescriber weighs your history against the labels.

Switching between them is routine, since it is the same drug at the same doses; a shortage or coverage change is the usual reason. Your logged dose and weight trend keep that transition clean rather than a guess.